Table 1.
Association between Covid-19 status and outcomes
| Variable investigated | Outcome Number (%) |
P-value | ||
|---|---|---|---|---|
| Deceased (n = 353) |
Recovered (n = 925) |
|||
| Continuous age - mean (SD) | 67.1 (15.9) | 53.0 (18.3) | 0.0001c | |
| Age (categorical) | 0–9 | 1 (0.3) | 12 (1.3) | 0.0001d |
| 10–19 | 1 (0.3) | 12 (1.3) | ||
| 20–29 | 4 (1.1) | 66 (7.1) | ||
| 30–39 | 15 (4.2) | 130 (14.1) | ||
| 40–49 | 25 (7.1) | 170 (18.4) | ||
| 50–59 | 47 (13.3) | 193 (20.9) | ||
| 60–69 | 104 (29.5) | 165 (17.8) | ||
| 70–79 | 74 (21.0) | 102 (11.0) | ||
| 80–89 | 62 (17.6) | 67 (7.2) | ||
| 90–99 | 19 (5.4) | 8 (0.9) | ||
| 100–109 | 1 (0.3) | 0 (0.0) | ||
| Sex | Female | 129 (36.5) | 356 (38.5) | 0.52d |
| Male | 224 (63.5) | 569 (61.5) | ||
| Therapeutic approach | Antiviral & antibiotic | 149 (42.2) | 401 (43.4) | 0.08d |
| Conservative | 71 (20.1) | 139 (15.0) | ||
| Antiviral | 133 (37.7) | 385 (41.6) | ||
| Specific medication used | Lopinavir/ritonavir and antibiotica | 131 (37.1) | 120 (13.0) | 0.001d |
| Oseltamivirb | 222 (62.9) | 805 (87.0) | ||
| Body temperature (C°) - mean (SD) | 37.6 (0.76) | 37.7 (0.73) | 0.09c | |
| Hospitalization (days) - median (IQR) | 9.0 (6.0–14.0) | 9.0 (6.0–14.0) | 0.18c | |
aprescribed for severe cases; bprescribed for mild cases; cMann–Whitney U test was used; dChi-square test was used